SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE‐BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS‐SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN
Tóm tắt
Từ khóa
Tài liệu tham khảo
All Wales Medicines Strategy Group.2011.AWMSG policy relating to ultra‐orphan medicines. Available:http://www.wales.nhs.uk/sites3/Documents/371/AWMSG%20policy%20relating%20to%20Ultra‐orphan%20Medicines%20Sep%2011.pdf[09 May 2012].
Department of Health.2009.NHS Chief Executive's Annual Report for 2008–09 May 2009. Available at:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_099700.pdf[15 July 2012].
Department of Health.2010a.The NHS Constitution for England. Available:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_113613[09 May 2012].
Department of Health.2010b.Impact assessment of a proposal for a Cancer Drugs Fund. Available:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_120930.pdf[09 May 2012].
Department of Health.2010c.Value‐based pricing impact assessment. Available:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_122823.pdf[09 May 2012].
Department of Health.2010d.A new value‐based approach to the pricing of branded medicines: a consultation. Available:http://www.dh.gov.uk/en/Consultations/Closedconsultations/DH_122760[09 May 2012].
Department of Health.2010e.The Cancer Drugs Fund: a consultation. Available:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_120931.pdf[09 May 2012].
Department of Health.2011.A new value‐based approach to the pricing of branded medicines – Government response to consultation. Available:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_128404.pdf[09 May 2012].
Dolan P, 2007, The Elgar companion to Health Economics, 382
FontainN HemilaK.2000.Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products. Official Journal of the European Communities. Available:http://ec.europa.eu/health/files/eudralex/vol‐1/reg_2000_141/reg_2000_141_en.pdf[09 May 2012].
FootC HarrisonT.2011.How to improve cancer survival: explaining England's relatively poor rates. The King's Fund. Available:http://www.kingsfund.org.uk/publications/cancer_survival.html[09 May 2012].
GreenbergD CohenJT NeumannPJ.2010.Are incremental benefits from new technology decreasing? An analysis of QALY gains over time. Proceedings of the 13thBiennial Society for Medical Decision Making European Meeting; Austria [abstract No.1].
Hughes D, 2011, Ring‐fencing a budget for cancer drugs: is it fair? Against, Journal of the Royal College of Physicians of Edinburgh, 41, 226
Institute for Fiscal Studies/Nuffield Trust.2012.NHS and social care funding: the outlook to 2021/22. Available:http://www.nuffieldtrust.org.uk/sites/files/nuffield/publication/120704_nhs‐social‐care‐funding‐outlook‐2021‐22_0.pdf[15 July 2012].
KindP HardmanG MacranS.1999.UK population norms for EQ‐5D. Discussion Paper 172 University of York Centre for Health Economics. Available:http://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20172.pdf[09 May 2012].
LinleyWG HughesDA.2012.Reimbursement decisions of the All Wales Medicines Strategy Group: influence of policy and clinical and economic factors. Pharmacoeconomics 2012 Jun 7. doi: 10.2165/11591530‐000000000‐00000. [Epub ahead of print] .
National Institute for Health and Clinical Excellence.2008a.Guide to the methods of technology appraisal. Available:http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf[09 May 2012].
National Institute for Health and Clinical Excellence.2008b.Social value judgements: principles for the development of NICE guidance 2ndEd. Available:http://www.nice.org.uk/media/C18/30/SVJ2PUBLICATION2008.pdf[09 May 2012].
National Institute for Health and Clinical Excellence.2008c.Report on NICE Citizens Council meeting: departing from the threshold. Available:http://www.nice.org.uk/media/231/CB/NICECitizensCouncilDepartingThresholdFinal.pdf[09 May 2012].
National Institute for Health and Clinical Excellence.2009.Supplementary advice to the appraisal committees: appraising life‐extending end of life medicines. Available:http://www.nice.org.uk/media/E4A/79/SupplementaryAdviceTACEoL.pdf[09 May 2012].
National Readership Survey.2010.NRS 2010 lifestyle data. Available:http://www.nrs.co.uk/lifestyle.html[09 May 2012].
NHS Specialised Services.2011.National specialised commissioning priorities 2011/12. Available:http://www.specialisedservices.nhs.uk/library/21/National_Specialised_Commissioning_Priorities_201112.pdf[09 May 2012].
Office for National Statistics.2009.General lifestyle survey 2009. Available:http://www.ons.gov.uk/ons/rel/ghs/general‐lifestyle‐survey/2009‐report/index.html[09 May 2012].
Office for National Statistics.2010.Nomis official labour force statistics: headline indicators 2011/12. Available:http://www.nomisweb.co.uk/tml/templates/data/LFS%20headline%20indicators.xls[09 May 2012]
Office for National Statistics.2011.Mid‐2010 population estimates for adults aged 16 years and over. Available:http://www.ons.gov.uk/ons/rel/pop‐estimate/population‐estimates‐for‐uk‐‐england‐and‐wales‐‐scotland‐and‐northern‐ireland/mid‐2010‐population‐estimates/rft‐‐‐mid‐2010‐population‐estimates.zip[09 May 2012].
RichardsM.2008.Improving access to medicines for NHS patients: a report for the Secretary of State for Health by Professor Mike Richards CBE. Available:http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_089952.pdf[09 May 2012].
Scottish Medicines Consortium.2010.SMC modifiers used in appraising new medicines. Available:http://www.scottishmedicines.org.uk/About_SMC/Policy_Statements/SMC_Modifiers_used_in_Appraising_New_Medicines[09 May 2012].
Walker A, 2009, How much good do new medicines do?, Basic & Clinical Pharmacology & Toxicology, 105, O29